Package 55150-327-25

{"route": ["INTRAMUSCULAR", "INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "c0bb9ae0-109a-4e3f-b300-a94e2721dddb", "openfda": {"upc": ["0355150327010"], "unii": ["F850569PQR"], "rxcui": ["1659929"], "spl_set_id": ["c7fa8d4f-28a7-4ef5-aef8-cbd4328ce599"], "manufacturer_name": ["Eugia US LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL, SINGLE-DOSE in 1 CARTON (55150-327-10)  / 1 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "55150-327-10", "marketing_start_date": "20191015"}, {"sample": false, "description": "25 VIAL, SINGLE-DOSE in 1 CARTON (55150-327-25)  / 1 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "55150-327-25", "marketing_start_date": "20191015"}], "brand_name": "Naloxone Hydrochloride", "product_id": "55150-327_c0bb9ae0-109a-4e3f-b300-a94e2721dddb", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Opioid Antagonist [EPC]", "Opioid Antagonists [MoA]"], "product_ndc": "55150-327", "generic_name": "Naloxone Hydrochloride", "labeler_name": "Eugia US LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Naloxone Hydrochloride", "active_ingredients": [{"name": "NALOXONE HYDROCHLORIDE", "strength": ".4 mg/mL"}], "application_number": "ANDA212455", "marketing_category": "ANDA", "marketing_start_date": "20191015", "listing_expiration_date": "20261231"}